Apolipoprotein E gene polymorphisms: a relationship with the risk of coronary artery disease and the effectiveness of lipid-lowering therapy with rosuvastatin
Aim. To analyze the associations of apolipoprotein E (APOE) gene polymorphisms (rs7412 and rs4420638) with the risk of coronary artery disease (CAD) and the effectiveness of lipid-lowering therapy with rosuvastatin.Material and methods. The study involved the analysis of deoxyribonucleic acid sample...
Main Authors: | M. I. Churilin, S. I. Kononov, Yu. V. Luneva, Yu. E. Azarova, E. Yu. Klesova, A. V. Kharchenko, S. N. Zhabin, O. Yu. Bushueva, S. V. Povetkin, G. S. Mal, M. A. Solodilova, A. V. Polonikov, V. A. Kazanov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2020-03-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2397 |
Similar Items
-
Rosuvastatin safety and efficacy in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2006-10-01) -
EFFECT OF ROSUVASTATIN ON CAROTID INTIMAMEDIA THICKNESS IN PATIENTS WITH CORONARY ARTERY DISEASE OF DIFFERENT GENDER AND CARDIOVASCULAR RISK PROFILE
by: S. I. Kononov, et al.
Published: (2018-05-01) -
Association of Common Variants of <i>APOE</i>, <i>CETP</i>, and the 9p21.3 Chromosomal Region with the Risk of Myocardial Infarction: A Prospective Study
by: Sergey Semaev, et al.
Published: (2023-06-01) -
An optimized method for PCR-based genotyping to detect human APOE polymorphisms
by: Leila Najd-Hassan-Bonab, et al.
Published: (2023-11-01) -
FAMILIAL DYSBETALIPOPROTEINEMIA (TYPE III HYPERLIPOPROTEINEMIA)
by: P. P. Malyshev, et al.
Published: (2019-03-01)